# V2 Receptor Effects on Fluid Regulation and Performance

> **NCT02084797** · NA · COMPLETED · sponsor: **Oakland University** · enrollment: 10 (actual)

## Conditions studied

- Electrolyte Imbalance
- Hyponatremia
- Hypernatremia

## Interventions

- **DRUG:** V2R (Vasopressin 2 receptor)

## Key facts

- **NCT ID:** NCT02084797
- **Lead sponsor:** Oakland University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-10
- **Final completion:** 2012-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02084797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02084797, "V2 Receptor Effects on Fluid Regulation and Performance". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02084797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*